Collectively, numerous complimentary and cross-validating approaches we took in our studies deliver a clear message that miR-141 possesses prostate tumour and metastasis suppressive functions via targeting critical molecules including CD44, Rho GTPases and EZH2. This evidence concerns the gene EZH2 and prostate neoplasm.